Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Waystar Holding Corp.(WAY) | 0 | 24,879,437 | +24,879,437 | $0 | $630.44M | 66.54% | +$630.44M |
| Pharvaris N.V.(PHVS) | 0 | 3,424,609 | +3,424,609 | $0 | $108.63M | 11.47% | +$108.63M |
| Oculis Holding Ag | 0 | 6,950,294 | +6,950,294 | $0 | $64.92M | 6.85% | +$64.92M |
| Agomab Therapeutics NvADS | 0 | 5,141,992 | +5,141,992 | $0 | $57.08M | 6.02% | +$57.08M |
| Evommune Inc | 0 | 5,288,313 | +5,288,313 | $0 | $43.68M | 4.61% | +$43.68M |
| Electra Therapeutics Inc | 0 | 3,795,281 | +3,795,281 | $0 | $42.70M | 4.51% | +$42.70M |